Preclinical antitumor efficacy of analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionate.
Corbett TH, LoRusso P, Demchick L, Simpson C, Pugh S, White K, Kushner J, Polin L, Meyer J, Czarnecki J, Heilbrun L, Horwitz JP, Gross JL, Behrens CH, Harrison BA, McRipley RJ, Trainor G.
Corbett TH, et al. Among authors: behrens ch.
Invest New Drugs. 1998;16(2):129-39. doi: 10.1023/a:1006174622061.
Invest New Drugs. 1998.
PMID: 9848576